文献速递肝病

序贯SAFE评分与瞬时弹性成像检测亚洲MASLD患者显著纤维化

Sequential SAFE Score and Transient Elastography for Detecting Significant Fibrosis in Asian Patients with MASLD.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-06-14

该研究比较SAFE、FIB-4和NFS在亚洲MASLD患者中检测显著纤维化(F≥2)的性能,并评估SAFE-TE序贯策略。研究假设先用SAFE可减少已存在F≥2但被误判为低风险的患者比例。

要点

  • SAFE评分近期被开发用于预测F≥2,外部验证优于FIB-4和NFS。
  • 国际指南提出先用FIB-4、非低风险者再用瞬时弹性成像的序贯步骤,但聚焦于F≥3。
  • 研究旨在比较SAFE、FIB-4和NFS性能,并评估SAFE-TE序贯方法。

核心结论

  • 研究假设先用SAFE可减少已存在F≥2但被误判为低风险的患者比例。

研究设计与样本

  • 研究比较SAFE、FIB-4和NFS在亚洲MASLD患者中检测F≥2的性能,并评估SAFE-TE序贯方法。

临床怎么用

  • 在初级保健机构中,F≥2者应转诊至肝病科医生;因此无创检测对MASLD患者风险分层至关重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD),1 represents a global public health issue. Fibrosis stage is the most important risk for long-term undesirable outcomes.2,3 From recent meta-analyses, all-cause and liver-related mortalities significantly increased from fibrosis stage 2 (significant fibrosis; F≥2) onward.4,5 In primary care setting, those with F≥2 should be referred to hepatologists; therefore, noninvasive tests to stratify risk of patients with MASLD are crucial. Steatosis-associated fibrosis estimator (SAFE) was recently developed to predict F≥2.6 SAFE has been externally validated and outperformed fibrosis-4 (FIB-4) and NAFLD fibrosis score (NFS).7,8 Recently, international guidelines proposed sequential diagnostic steps, initially using FIB-4 and then transient elastography (TE) in non-low-risk patients.9,10 However, the guidelines focused on identifying advanced fibrosis (F≥3), which might be too late. This study aimed to compare the performance among SAFE, FIB-4, and NFS, and evaluate SAFE-TE sequential approach. We hypothesized that by initially using SAFE, the proportion of patients misclassified as low risk despite already having F≥2 could be diminished.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kaewdech A, Sripongpun P, Treeprasertsuk S, et al. Sequential SAFE Score and Transient Elastography for Detecting Significant Fibrosis in Asian Patients with MASLD. Clin Gastroenterol Hepatol. 2024. PMID: 38880124. doi:10.1016/j.cgh.2024.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。